Diabetes, depression, and death: A randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT)

Diabetes Care

Volumn 30, Issue 12, 2007, Pages 3005-3010

  Bogner, Hillary R ^a   Morales, Knashawn H ^a   Post, Edward P ^b,c   Bruce, Martha L ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PRIMARY MEDICAL CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; DEPRESSION; DEPRESSIVE DISORDER; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PENNSYLVANIA; PRIMARY HEALTH CARE; SURVIVAL ANALYSIS;

EID: 37149039852     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0974     Document Type: Article

References (41)

1. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE: Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care 19:1097-1102, 1996
2. Eaton WW: Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 53:903-906, 2002
3. Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 19:113-122, 2005
4. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ: Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619-630, 2001
5. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB: Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241-250, 1997
6. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE: Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 129:613-621, 1998
7. Lustman PJ, Freedland KE, Griffith LS, Clouse RE: Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23:618-623, 2000
8. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T: The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042-1049, 2004
9. Williams JW, Katon W, Lin EHB, Nöel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unützer J; IMPACT Investigators: The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140:1015-1024, 2004
10. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS: Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161:652-660, 2005
11. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von Korff M: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668-2672, 2005
12. Black SA, Markides KS, Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26:2822-2828, 2003
13. Egede LE, Nietert PJ, Zheng D: Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28:1339-1345, 2005
14. Bruce ML, Ten Have TR, Reynolds CF 3rd, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS: Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 291:1081-1091, 2004
15. Ezzati M, Jamison DT, Lopez AD, Mathers CD, Murray C, Eds.: Global Burden of Disease and Risk Factors. Washington, DC, Oxford University Press and World Bank, 2006
16. Gallo JJ, Bogner HR, Morales KH, Post EP, Ten Have T, Bruce ML: Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry 13:748-755, 2005
17. Carter GM, Bell RM, Dubois RW, Goldberg GA, Keeler EB, McAlearney JS, Post EP, Rumpel JD: A clinically detailed risk information system for cost. Health Care Financ Rev 21:65-91, 2000
18. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas 1:385-401, 1977
19. Schulberg HC, Post EP, Raue PJ, Have TT, Miller M, Bruce ML: Treating late-life depression with interpersonal psychotherapy in the primary care sector. Int J Geriatr Psychiatry 22:106-14, 2007
20. Spitzer RL, Gibbon M, Williams JB: Structured Clinical Interview for Axis I DSM-IV Disorders (SCID). Washington, DC, American Association Press, 1995
21. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62, 1960
22. Charlson ME, Pompei P, Ales KL, Mac-Kenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
23. Lawton MP, Moss M, Fulcomer M, Kleban MH: A research and service oriented multilevel assessment instrument. J Gerontol 37:91-99, 1982
24. Beck A, Brown G, Steer R: Psychometric characteristics of the scale for suicide: ideation with psychiatric outpatients. Behav Res Ther 35:1039-1046, 1997
25. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975
26. Doody MM, Hayes HM, Bilgrad R: Comparability of national death index plus and standard procedures for determining causes of death in epidemiologic studies. Ann Epidemiol 11:46 -50, 2001
27. Lee E, Wei L, Amato D: Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In Survival Analysis. Norwell, MA, Kluwer Academic Publishers, 1992
28. Bogner HR, Ford DE, Gallo JJ: The role of cardiovascular disease in the identification and management of depression by primary care physicians. Am J Geriatr Psychiatry 14:71-78, 2006
29. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457- 481, 1958
30. Rothwell PM: Treating individuals. 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365:176-186, 2005
31. Oxman AD, Guyatt GH: A consumer's guide. Ann Intern Med 116:78-84, 1992
32. Fleiss JL: Analysis of data from multiclinic trials. Control Clin Trials 7:267-75, 1986
33. Bowlin SJ, Morrill BD, Nafziger AN, Lewis C, Pearson TA: Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey. J Clin Epidemiol 49:511-517, 1996
34. Sathiakumar N, Delzell E, Abdalla O: Using the National Death Index to obtain underlying cause of death codes. J Occup Environ Med 40:808-813, 1998
35. Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce ML: The effect on mortality of a practice-based depression intervention program for older adults in primary care: a cluster randomized trial. Ann Intern Med 146:689-698, 2007
36. Kravitz RL, Duan N, Braslow J: Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q 82:661-687, 2004
37. Senn S: Individual response to treatment: BMJ 329:966-968, 2004
38. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54:317-329, 2003
39. Joynt KE, Whellan DJ, O'Connor CM: Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 54:248-261, 2003
40. Lu M, Lyden PD, Brott TG, Hamilton S, Broderick JP, Grotta JC: Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research. J Neurosci Methods 143:209-216, 2005
41. Buyse M: Analysis of clinical trial outcomes: some comments on subgroup analysis. Control Clin Trials 10 (Suppl. 4):187S-194S, 1989